Mass-Like Extreme Wall Thickening of the Entire Common Bile Duct in a Case of Portal Cavernoma Cholangiopathy

Abstract

Portal cavernoma cholangiopathy (PCC) refers to the cholangiographic abnormalities that occur in patients with portal cavernoma. These abnormalities may be either due to chronic portal vein thrombosis or extrahepatic portal vein occlusion. These abnormalities occur due to enlargement of the bridging tortuous paracholedochal, epicholedochal, and cholecystic veins exerting pressure on the bile ducts. Ischemic changes can also occur in the bile duct due to portal vein thrombosis, which affects the microvascular circulation or associated hepatic artery thrombosis. These may be either reversible with shunt procedures such as transjugular intrahepatic portosystemic shunt (TIPS) or irreversible in the advanced stage, leading to recurrent episodes of biliary pain, cholangitis, and cholestasis. Occasionally it may present as mass-like diffuse common bile duct (CBD) wall thickening, which may be confused with mimickers like primary CBD lymphoma, immunoglobulin G4-related sclerosing cholangitis, and even cholangiocarcinoma on imaging. Thus, we need to be aware of the mass-forming PCC imaging findings to avoid unnecessary invasive procedures like biopsy or surgical intervention. Here, we present a case of PCC, which presented as mass-like diffuse CBD wall thickening with patent lumen on ultrasound that led to further workup with contrast-enhanced computed tomography and magnetic resonance imaging. The wall thickening showed persistent delayed enhancement, no significant diffusion restriction, and there was also associated superior mesenteric vein thrombosis with multiple mesenteric collaterals. A positron emission tomography-CT scan also ruled out malignant disease as there was no uptake. Finally, a diagnosis of mass-forming PCC was made by combining imaging features and excluding other causes.

Keywords

common bile duct - magnetic resonance imaging - portal vein

Publikationsverlauf

Artikel online veröffentlicht:
02. November 2021

• References

• 1 Fraser J, Brown AK. A clinical syndrome associated with a rare anomaly of the vena portal system. Surg Gynecol Obstet 1944; 78: 520
• 2 Dhiman RK, Saraswat VA, Valla DC. et al. Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver. J Clin Exp Hepatol 2014; 4 (Suppl. 01) S2-S14
• 3 Walser EM, Runyan BR, Heckman MG. et al. Extrahepatic portal biliopathy: proposed etiology on the basis of anatomic and clinical features. Radiology 2011; 258 (01) 146-153
• 4 Khuroo MS, Rather AA, Khuroo NS, Khuroo MS. Portal biliopathy. World J Gastroenterol 2016; 22 (35) 7973-7982
• 5 Sharma M, Rameshbabu CS. Portal cavernoma cholangiopathy: an endoscopic ultrasound based imaging approach. J Clin Exp Hepatol 2014; 4 (Suppl. 01) S53-S61
• 6 Kessler A, Graif M, Konikoff F. et al. Vascular and biliary abnormalities mimicking cholangiocarcinoma in patients with cavernous transformation of the portal vein: role of color Doppler sonography. J Ultrasound Med 2007; 26 (08) 1089-1095
• 7 Hulshoff JB, Cuperus FJC, de Haas RJ. Mass-forming portal biliopathy presenting as extreme wall-thickening of the common bile duct. Diagnostics (Basel) 2020; 10 (09) 623
• 8 Tartar VM, Balfe DM. Lymphoma in the wall of the bile ducts: radiologic imaging. Gastrointest Radiol 1990; 15 (01) 53-57
• 9 Zakaria A, Al-Obeidi S, Daradkeh S. Primary non-Hodgkin's lymphoma of the common bile duct: a case report and literature review. Asian J Surg 2017; 40 (01) 81-87
• 10 Madhusudhan KS, Das P, Gunjan D, Srivastava DN, Garg PK. IgG4-related sclerosing cholangitis: a clinical and imaging review. AJR Am J Roentgenol 2019; 213 (06) 1221-1231
• 11 Cellich PP, Crawford M, Kaffes AJ, Sandroussi C. Portal biliopathy: multidisciplinary management and outcomes of treatment. ANZ J Surg 2015; 85 (07/08) 561-566